David Larsen is ranked #272 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

BTIG

David Larsen

Q: How accurate are David Larsen's stock ratings?

About 60% of David's ratings were profitable over a one-year hold, with an average return of +19.4% per rating, measured by 13Foresight from historical prices.

BTIG

Wall Street Analyst

★★★★★

#272

on 13Foresight · ranked by our own returns

62%

Success Rate

+18.8%

Average Return

32 of 52 calls profitable · +33.2% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

🔒 3-year track record is Pro. Showing 1-year — upgrade.

📈 Across the calls we could measure, roughly 62% of David Larsen's ratings turned a profit when each position was held for 1 year — averaging +18.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

78 Buy 32 Hold 0 Sell

David's Stock Coverage 35 ratings · 2026-07-30

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
CCSI Consensus Cloud Solutions	Jul 24, 2026	BUY	Buy -16.6% avg upside 6 analysts	$45.00 22.61% Upside	·	·
LFST Lifestance Health Group	Jul 24, 2026	BUY	Strong Buy +0.8% avg upside 15 analysts	$15.00 38.17% Upside	-2.0%	·
PGNY Progyny	Jul 24, 2026	BUY	Strong Buy +4.6% avg upside 14 analysts	$40.00 27.42% Upside	-2.6%	·
HQY Healthequity	Jul 24, 2026	BUY	Strong Buy +10.4% avg upside 20 analysts	$115.00 10.45% Upside	+6.7%	·
CYRX CryoPort	Jul 24, 2026	BUY	Strong Buy +0.1% avg upside 15 analysts	$25.00 67.48% Upside	+0.0%	·
OMDA Omada Health, Inc.	Jul 17, 2026	BUY	Strong Buy +25.8% avg upside 12 analysts	$30.00 53.01% Upside	-13.4%	·
EVH Evolent Health	Jul 16, 2026	BUY	Strong Buy +200.3% avg upside 19 analysts	$8.00 142.33% Upside	-41.8%	·
ASTH Astrana Health	Jul 16, 2026	BUY	Strong Buy +54.3% avg upside 16 analysts	$65.00 78.00% Upside	-9.1%	·
TOI Oncology Institute	Jul 15, 2026	BUY	Strong Buy +32.6% avg upside 7 analysts	$9.00 88.62% Upside	-14.8%	·
BTSG BrightSpring Health Services, Inc.	Jul 06, 2026	BUY	Strong Buy -5.2% avg upside 20 analysts	$90.00 29.75% Upside	+3.3%	·
SLP Simulations Plus	Jun 16, 2026	HOLD	Buy +106.8% avg upside 11 analysts	$18.50 0.95% Upside	+0.5%	·
HSIC Henry Schein	Jun 11, 2026	BUY	Buy +1.7% avg upside 25 analysts	$100.00 16.41% Upside	+6.0%	·
MDLN Medline	Jun 09, 2026	BUY	Strong Buy +26.1% avg upside 26 analysts	$55.00 37.18% Upside	+8.6%	·
VEEV Veeva Systems	Jun 03, 2026	BUY	Strong Buy +15.2% avg upside 37 analysts	$340.00 63.54% Upside	+12.8%	·
DOCS Doximity	May 14, 2026	HOLD	Buy +52.2% avg upside 28 analysts	—	+13.6%	·
DCGO DocGo	May 12, 2026	HOLD	Buy +316.4% avg upside 7 analysts	—	+5.0%	·
HCAT Health Catalyst	May 12, 2026	HOLD	Buy +161.6% avg upside 15 analysts	—	+35.8%	·
DH Definitive Healthcare Corp	May 11, 2026	HOLD	Hold +665.7% avg upside 19 analysts	—	-30.6%	·
LFMD LifeMD	May 07, 2026	BUY	Strong Buy +215.6% avg upside 14 analysts	$10.00 174.63% Upside	-13.8%	·
AMWL American Well	May 05, 2026	HOLD	Hold +33.0% avg upside 15 analysts	—	+69.3%	·
TDOC Teladoc	Apr 30, 2026	HOLD	Buy +230.6% avg upside 37 analysts	—	+42.9%	·
OMCL Omnicell	Apr 28, 2026	HOLD	Strong Buy +31.7% avg upside 12 analysts	—	-12.4%	·
HIMS Hims & Hers Health	Mar 05, 2026	HOLD	Buy +4.0% avg upside 22 analysts	—	+57.4%	·
IQV IQVIA Holdings	Feb 05, 2026	HOLD	Strong Buy -2.7% avg upside 39 analysts	—	+31.4%	·
PIII P3 Health Partners	Nov 14, 2025	HOLD	Buy +1815.5% avg upside 8 analysts	—	+36.1%	·
AGL Agilon Health	Nov 04, 2025	HOLD	Buy -46.0% avg upside 26 analysts	—	+411.9%	·
PRVA Privia Health Group	Mar 05, 2025	BUY	Strong Buy +31.4% avg upside 26 analysts	$35.00 45.18% Upside	-7.2%	·
BBLNF Babylon Holdings	Jun 23, 2023	HOLD	Buy +65549900.0% avg upside 6 analysts	—	·	·
CRL Charles River Labs	Aug 14, 2019	HOLD	Strong Buy -10.2% avg upside 34 analysts	—	+69.5%	·
CVS CVS Health	Aug 14, 2019	HOLD	Strong Buy -1.5% avg upside 39 analysts	—	+15.6%	·
COR Cencora	Aug 14, 2019	HOLD	Buy -1.5% avg upside 43 analysts	—	+30.1%	·
CAH Cardinal Health	Nov 16, 2018	HOLD	Buy -13.8% avg upside 29 analysts	$55.00 76.04% Downside	+5.7%	·
ACH Accendra Health	Oct 31, 2018	HOLD	Hold +427.0% avg upside 17 analysts	$9.00 171.12% Upside	-13.7%	·
MCK McKesson	May 29, 2018	HOLD	Strong Buy -16.9% avg upside 27 analysts	$160.00 81.96% Downside	-10.2%	·
MDRX Veradigm	Jun 19, 2017	HOLD	Buy +195.2% avg upside 22 analysts	$13.00 159.97% Upside	+2.7%	·

🔒 30 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

David Larsen — Frequently Asked Questions

How accurate are David Larsen's stock ratings?

Based on the calls 13Foresight could measure, about 60% of David's ratings were profitable over a one-year hold, with an average return of +19.4% per rating, or +15.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is David ranked on 13Foresight?

David Larsen is currently ranked #272 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does David cover?

David most recently has ratings on CCSI, LFST, PGNY, HQY, CYRX, OMDA, EVH, ASTH, TOI, BTSG, SLP, HSIC and 23 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

David Larsen

Rating Distribution

Welcome to 13Foresight!